Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
Also known as: Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11714 | Durvalumab | 0 | Active Not Recruiting | 1 |
DB11771 | Tremelimumab | 0 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 2 | Active Not Recruiting | 1 |
DB00958 | Carboplatin | 2 | Terminated | 1 |
DB00515 | Cisplatin | 2 | Terminated | 1 |
DB00694 | Daunorubicin | 2 | Terminated | 1 |
DB00997 | Doxorubicin | 2 | Terminated | 1 |
DB11714 | Durvalumab | 2 | Terminated | 1 |
DB00441 | Gemcitabine | 2 | Terminated | 1 |
DB00563 | Methotrexate | 2 | Terminated | 1 |
DB00642 | Pemetrexed | 2 | Active Not Recruiting | 1 |
DB12257 | Platinum | 2 | Terminated | 1 |
DB14546 | Sulfate ion | 2 | Terminated | 1 |
DB00570 | Vinblastine | 2 | Terminated | 1 |